An organoids biobank for recapitulating tumor heterogeneity and personalized medicine

被引：9
|
作者：
Yang, Hui [1 ]
Zhang, Ning [1 ]
Liu, Yu-Cun [1 ]
机构：
[1] Peking Univ First Hosp, Translat Canc Res Ctr, Beijing 100034, Peoples R China
来源：
CHINESE JOURNAL OF CANCER RESEARCH | 2020年 / 32卷 / 03期
关键词：
IN-VITRO EXPANSION; STEM-CELLS; LONG-TERM; CULTURES; MODELS;
D O I：
10.21147/j.issn.1000-9604.2020.03.12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：408 / 413
页数：6
相关论文
共 50 条
  • [41] Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
    Molinari, Chiara
    Marisi, Giorgia
    Passardi, Alessandro
    Matteucci, Laura
    De Maio, Giulia
    Ulivi, Paola
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
  • [42] Lung Tumor Patient Derived Organoids Including Vasculature and Mesenchymal Stem Cells as a New Tool for Personalized Medicine
    Seitlinger, J.
    Chaddad, H.
    Lindner, V.
    Akasov, R.
    Markvicheva, E.
    Chenard, M. P.
    Olland, A.
    Falcoz, P. E.
    Massard, G.
    Benkirane-Jessel, N.
    Idoux-Gillet, Y.
    STEM CELLS AND REGENERATIVE MEDICINE, 2019, 79 : 131 - 138
  • [43] INDUCTION OF BRANCHING MORPHOGENESIS IN CHOLANGIOCARCINOMA ORGANOIDS IN VITRO IMPROVES SIMILARITY WITH THE ORIGINAL TUMOR FOR ENHANCED PERSONALIZED MEDICINE APPLICATIONS
    Van Tienderen, Gilles
    Monfils, Kathryn
    Roos, Floris
    Van der Laan, Luc
    Verstegen, Monique
    TISSUE ENGINEERING PART A, 2023, 29 (11-12) : 140 - 141
  • [44] Cellular Metabolic Heterogeneity In Vivo Is Recapitulated in Tumor Organoids
    Sharick, Joe T.
    Jeffery, Justin J.
    Karim, Mohammad R.
    Walsh, Christine M.
    Esbona, Karla
    Cook, Rebecca S.
    Skala, Melissa C.
    NEOPLASIA, 2019, 21 (06): : 615 - 626
  • [45] Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasis
    Conti, Alessandro
    Santoni, Matteo
    Sotte, Valeria
    Burattini, Luciano
    Scarpelli, Marina
    Cheng, Liang
    Lopez-Beltran, Antonio
    Montironi, Rodolfo
    Cascinu, Stefano
    Muzzonigro, Giovanni
    Lund, Lars
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (07) : 303 - 309
  • [46] Recapitulating spatiotemporal tumor heterogeneity in vitro through engineered breast cancer microtissues
    Mazio, Claudia
    Casale, Costantino
    Imparato, Giorgia
    Urciuolo, Francesco
    Netti, Paolo Antonio
    ACTA BIOMATERIALIA, 2018, 73 : 236 - 249
  • [47] TOWARDS THE DEVELOPMENT OF HUMAN-BASED BONE ORGANOIDS FOR PERSONALIZED MEDICINE
    de Leeuw, Anke
    Kodiyan, Ben
    Zhang, Jianhua
    Lim, Pei Jin
    Ruger, Matthias
    Rohrbach, Marianne
    Giunta, Cecilia
    Muller, Ralph
    Rubert, Marina
    TISSUE ENGINEERING PART A, 2022, 28 : S424 - S424
  • [48] Outcomes and Utility of TTR Reporting in the Colorado Center for Personalized Medicine Biobank
    Crooks, K.
    Axell, L.
    Kao, D.
    Ku, L.
    Rafaels, N.
    Shortt, J.
    Todd, E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S3 - S3
  • [49] Pancreatic cancer patient-derived organoids as a tool for personalized medicine
    Tiriac, Herve
    CANCER RESEARCH, 2020, 80 (16)
  • [50] Tumor Heterogeneity as the Foundation of Personalized Cancer Treatment
    Schilsky, Richard L.
    SEMINARS IN ONCOLOGY, 2011, 38 (02) : 171 - 172
12345